List of pharmabiotics patents

Patent 11536632 was granted and assigned to DNA Genotek on December, 2022 by the United States Patent and Trademark Office.

Patent 11549870 was granted and assigned to DNA Genotek on January, 2023 by the United States Patent and Trademark Office.

Patent 11650159 was granted and assigned to Takeda Pharmaceutical Company on May, 2023 by the United States Patent and Trademark Office.

Patent 11518078 was granted and assigned to CSP Technologies, Inc. on December, 2022 by the United States Patent and Trademark Office.

Patent 11583563 was granted and assigned to Takeda Pharmaceutical Company on February, 2023 by the United States Patent and Trademark Office.

Patent 11559288 was granted and assigned to CSP Technologies, Inc. on January, 2023 by the United States Patent and Trademark Office.

Patent 11536726 was granted and assigned to Metabolon on December, 2022 by the United States Patent and Trademark Office.

Patent 7483530 was granted and assigned to POSTECH on January, 2009 by the United States Patent and Trademark Office.

Patent 7809601 was granted and assigned to Johnson & Johnson on October, 2010 by the United States Patent and Trademark Office.

Patent 11387087 was granted and assigned to Metabolon on July, 2022 by the United States Patent and Trademark Office.

Patent 11338152 was granted and assigned to Johnson & Johnson on May, 2022 by the United States Patent and Trademark Office.

Patent 7522686 was granted and assigned to POSTECH on April, 2009 by the United States Patent and Trademark Office.

Patent 11571704 was granted and assigned to Johnson & Johnson on February, 2023 by the United States Patent and Trademark Office.

Patent 11534467 was granted and assigned to Eligo Bioscience on December, 2022 by the United States Patent and Trademark Office.

Patent 11376286 was granted and assigned to Eligo Bioscience on July, 2022 by the United States Patent and Trademark Office.

Patent 11622751 was granted and assigned to Johnson & Johnson on April, 2023 by the United States Patent and Trademark Office.

Patent 11619636 was granted and assigned to Metabolon on April, 2023 by the United States Patent and Trademark Office.

Patent 7314754 was granted and assigned to Takeda Pharmaceutical Company on January, 2008 by the United States Patent and Trademark Office.

Patent 11344056 was granted and assigned to CSP Technologies, Inc. on May, 2022 by the United States Patent and Trademark Office.

Patent 11352177 was granted and assigned to CSP Technologies, Inc. on June, 2022 by the United States Patent and Trademark Office.

Patent 11640661 was granted and assigned to Johnson & Johnson on May, 2023 by the United States Patent and Trademark Office.

Patent 7431942 was granted and assigned to Takeda Pharmaceutical Company on October, 2008 by the United States Patent and Trademark Office.

Patent 7396526 was granted and assigned to Johnson & Johnson on July, 2008 by the United States Patent and Trademark Office.